Burkholderia pseudomallei causes melioidosis, an emerging disease in tropical areas such as South-east Asia and northern Australia, with a high fatality rate. It usually presents as a severe pneumonia or septicaemia, although subclinical infection is also seen, and relapses are common. Infection often responds poorly to antibiotic treatment, and alternative therapies are urgently required.The reservoir of B. pseudomallei is soil and stagnant water. The closely related species, B. thailandensis, is also found in these environments but is not pathogenic in humans. In a Syrian hamster model of septicaemia, the lethal dose that kills 50% of animals tested (LD50) of B. pseudomallei is ten organisms, whereas for B. thailandensis it is 106. Reckseidler et al. 1xDetection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Reckseidler, S.L et al. Infect. Immun. 2001; 69: 34–44Crossref | PubMed | Scopus (184)See all References1 have now exploited this difference, using subtractive hybridization to identify genes that are present in B. pseudomallei and not B. thailandensis, with the aim of identifying those necessary for virulence. One of the unique genes identified showed weak sequence homology to a Pseudomonas aeruginosa glycosyltransferase that is involved in capsule synthesis. Following this clue, the team then constructed a strain of B. pseudomallei with a mutation in this gene (wbpX). In the hamster model, the LD50 of the mutant was 3.5×105 organisms, thus demonstrating the role of wbpX in pathogenesis.As it was hypothesized that wbpX was also involved in capsule synthesis, the authors visualized the bacterial capsule using immunogold staining, and compared wild-type to mutant strains. The mutant strain was found to be deficient in type I O-polysaccharide (O-PS) moieties found on the cell surface. Further sequencing of the B. pseudomallei chromosome around wbpX identified a large cluster of genes, all of which are either predicted or proven to be necessary for type I O-PS synthesis or transport. These genes showed sequence homology to group 3 capsule genes found in other pathogens such as Neisseria meningitidis, Haemophilus influenzae, and Escherichia coli. Furthermore, this region has a G+C content that is unusually low for B. pseudomallei, suggesting it is encoded on a pathogenicity island that has been horizontally acquired from another bacteria. It is therefore possible that the acquisition of these genes has enabled B. pseudomallei to become a pathogen.Capsules often make good targets for bacterial vaccines. Before a vaccine to melioidosis can be developed, it will be necessary to prove that antibody to group 3 capsule is protective, and that protective antibodies are induced after vaccination. If successful, such a vaccine might be particularly useful for visitors to endemic countries, as well as preventing disease in high-risk populations and relapse in seropositive patients.
Read full abstract